BEIJING, September 7, 2022 – George Clinical, a global clinical research organization with an extensive presence throughout the Asia-Pacific region, continues to expand the organization’s team in China with the addition of Helen Xu as Project Director and Cell Gene Therapy Head. She will be based in Beijing and joins a rapidly growing team responsible […]
Read MoreGillian Ryan joined George Clinical in the spring of 2021 with over 20 years of experience in the pharmaceutical industry including experience working in, and with, large pharma companies and clinical research organizations, across all phases of drug development and many therapeutic areas. Gillian’s experience spans both project operations and medical affairs and she holds […]
Read MoreIBM recently highlighted the success George Clinical has enjoyed over the past several years leveraging the firm as a data, analytics and technology partner. The white paper, “Achieving Healthy CRO Growth Through Agility” was published with input from George Clinical Head of Data Management, Ullas Arabhavi. The paper describes how nearly a decade ago, the […]
Read MoreGeorge Clinical announces that it has achieved a Bronze Medal from EcoVadis, the world’s most trusted provider of business sustainability ratings. This is the first time the organization has pursued certification and earned a medal from EcoVadis. An EcoVadis Rating validates the organization’s business sustainability commitments and performance. George Clinical’s score places the company in […]
Read MoreA new multi-faceted partnership supported by George Clinical will move to the forefront of the cancer treatment revolution. The Precision Oncology Screening Platform Enabling Clinical Trials (PrOSPeCT) will establish Australia as a medical manufacturing hub building links from research through to the clinic; creating jobs and changing lives. Over the past decade, immunotherapy and other […]
Read MoreIt is a proud moment for George Clinical, India to collaborate with Project NIRAMAYA, a program for “Creation of Livelihood opportunities through Skill Development in the field of ‘Home Nursing’. In its two-fold agenda of providing sustainable healthcare support to the elderly with unmet needs in rural sectors, this program extends social and financial support […]
Read MoreThe 4th Annual Chronic Kidney Disease Drug Development (CKD3) Summit saw a select group of scientists, clinical researchers and experts from industry and regulatory agencies gathered face-to-face for the first time since the pandemic. Excitement and enthusiasm were evident as these experts networked and collaborated on how the latest scientific research is being applied to […]
Read MoreThe UPcare Group is now advancing to human trials with George Clinical with trials to begin soon. UPcare’s human trials are based on their previous pre-clinical and real-world data. Pre-clinical trial results conducted by The Doherty institute in 2020 indicated that compounds used in UPCare’s formulations and products are up to 99.99% effective at inhibiting […]
Read MoreOVERLAND PARK, KS., March 1, 2022 – George Clinical announces the expansion of its renal scientific leadership into Latin America with the addition of subject matter expert Hernán Trimarchi, MD, PHD, FACP, FASN. Dr. Trimarchi’s research focuses on glomerular diseases, particularly proteinuria and podocyturia, IgA nephropathy, focal segmental glomerulosclerosis, and Fabry disease. He is Head […]
Read MoreSYDNEY, February 2, 2022 – George Clinical announces that the organization has been accredited by the Australian Office of the Gene Technology Regulator (OGTR) which allows it to be a licence holder for studies involving the use of genetically modified organisms (GMOs). The addition of this capability means that George Clinical can now, under the […]
Read More
